Maintenance. We are currently updating the site. Please check back shortly

Thomson Reuters Foundation

Inform - Connect - Empower

Tekmira says discussing Ebola treatment with governments, NGOs

Source: Reuters - Wed, 13 Aug 2014 20:54 GMT
Author: Reuters
hum-dis
Tweet Recommend Google + LinkedIn Email Print
Leave us a comment

TORONTO, Aug 13 (Reuters) - Canada's Tekmira Pharmaceuticals Corp said on Wednesday it was discussing options for its experimental Ebola treatment with governments and other agencies, including the World Health Organization.

The company said it was in talks on whether its drug could be used to treat patients infected with the deadly virus, "within accepted clinical and regulatory protocols."

"Our therapeutic, TKM-Ebola, is currently an unapproved agent and the regulatory framework to support its use in Africa has not yet been established," Tekmira said in a statement.

"Given the severity of the situation, we are carefully evaluating options for use of our investigational drug ... this includes discussions with government agencies and NGO's, including the WHO, in various countries on the potential use of TKM-Ebola to treat Ebola virus infected individuals." (Reporting by Allison Martell; Editing by David Gregorio)

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of the Thomson Reuters Foundation. For more information see our Acceptable Use Policy.

comments powered by Disqus
Most Popular
TOPICAL CONTENT
Topical content
LATEST SLIDESHOW

Latest slideshow

See allSee all
FEATURED JOBS
Featured jobs